UBS Group AG Boosts Stock Position in Embecta Corp. $EMBC

UBS Group AG boosted its stake in Embecta Corp. (NASDAQ:EMBC) by 200.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 630,994 shares of the company’s stock after acquiring an additional 421,254 shares during the period. UBS Group AG owned 1.07% of Embecta worth $7,496,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of EMBC. JPMorgan Chase & Co. raised its holdings in shares of Embecta by 39.5% during the third quarter. JPMorgan Chase & Co. now owns 434,822 shares of the company’s stock worth $6,135,000 after purchasing an additional 123,113 shares during the period. Jefferies Financial Group Inc. boosted its stake in Embecta by 40.4% in the third quarter. Jefferies Financial Group Inc. now owns 1,884,875 shares of the company’s stock valued at $26,596,000 after acquiring an additional 542,162 shares during the period. Public Sector Pension Investment Board lifted its holdings in shares of Embecta by 57.7% in the 3rd quarter. Public Sector Pension Investment Board now owns 314,129 shares of the company’s stock worth $4,432,000 after purchasing an additional 114,902 shares during the last quarter. Teacher Retirement System of Texas lifted its stake in Embecta by 365.7% in the third quarter. Teacher Retirement System of Texas now owns 372,451 shares of the company’s stock valued at $5,255,000 after buying an additional 292,477 shares during the last quarter. Finally, SG Americas Securities LLC bought a new stake in Embecta in the fourth quarter valued at $5,178,000. Institutional investors own 93.83% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on EMBC shares. BTIG Research downgraded Embecta from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 5th. Bank of America dropped their price target on shares of Embecta from $11.00 to $3.00 and set an “underperform” rating on the stock in a research report on Monday. Weiss Ratings downgraded Embecta from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, May 6th. Zacks Research cut Embecta from a “hold” rating to a “strong sell” rating in a research note on Friday, May 8th. Finally, Mizuho reduced their target price on shares of Embecta from $12.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Two equities research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Sell” and an average price target of $11.00.

Embecta Stock Down 3.5%

Embecta stock opened at $3.03 on Tuesday. Embecta Corp. has a 12 month low of $2.99 and a 12 month high of $15.55. The stock has a market cap of $179.76 million, a P/E ratio of 1.59 and a beta of 1.09. The company’s fifty day simple moving average is $7.91 and its 200-day simple moving average is $10.52.

Embecta (NASDAQ:EMBC) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.15). Embecta had a net margin of 10.73% and a negative return on equity of 23.96%. The firm had revenue of $221.80 million during the quarter, compared to the consensus estimate of $235.67 million. During the same period in the previous year, the firm posted $0.70 EPS. The company’s quarterly revenue was down 14.4% compared to the same quarter last year. Embecta has set its FY 2026 guidance at 1.550-1.75 EPS. On average, equities research analysts expect that Embecta Corp. will post 1.58 earnings per share for the current fiscal year.

Embecta Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Thursday, May 28th will be paid a $0.01 dividend. The ex-dividend date is Thursday, May 28th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.3%. Embecta’s payout ratio is presently 2.11%.

Embecta Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.